Renovorx ceo shaun r. bagai to present at the aegis capital virtual conference on may 9, 2024

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that shaun r. bagai, chief executive officer, will present at the aegis capital virtual conference being held on may 7-9, 2024. mr. bagai will discuss recent corporate milestones, including the completion of private placements in january and april 2024 in.
RNXT Ratings Summary
RNXT Quant Ranking